314 related articles for article (PubMed ID: 6183287)
1. Changes in the metabolism of dihydrotestosterone in the hyperplastic human prostate.
Isaacs JT; Brendler CB; Walsh PC
J Clin Endocrinol Metab; 1983 Jan; 56(1):139-46. PubMed ID: 6183287
[TBL] [Abstract][Full Text] [Related]
2. Changes in dihydrotestosterone metabolism and the development of benign prostatic hyperplasia in the aging beagle.
Isaacs JT
J Steroid Biochem; 1983 Jun; 18(6):749-57. PubMed ID: 6191128
[TBL] [Abstract][Full Text] [Related]
3. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
4. Increased ratio of 5 alpha-reductase: 3 alpha (beta)-hydroxysteroid dehydrogenase activities in the hyperplastic human prostate.
Bruchovsky N; Lieskovsky G
J Endocrinol; 1979 Mar; 80(3):289-301. PubMed ID: 86594
[TBL] [Abstract][Full Text] [Related]
5. Androgen metabolism in the epithelial and stromal components of the human hyperplastic prostate.
Habib FK; Tesdale AL; Chisholm GD; Busuttil A
J Endocrinol; 1981 Oct; 91(1):23-32. PubMed ID: 6170712
[TBL] [Abstract][Full Text] [Related]
6. Effect of aging on kinetic parameters of 3 alpha(beta)-hydroxysteroid oxidoreductases in epithelium and stroma of human normal and hyperplastic prostate.
Tunn S; Haumann R; Hey J; Flüchter SH; Krieg M
J Clin Endocrinol Metab; 1990 Sep; 71(3):732-9. PubMed ID: 1697599
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of androgens in human hyperplastic prostate: evidence for a differential localization of the enzymes involved in the metabolism.
Abalain JH; Quemener E; Carre JL; Simon B; Amet Y; Mangin P; Floch HH
J Steroid Biochem; 1989; 34(1-6):467-71. PubMed ID: 2483221
[TBL] [Abstract][Full Text] [Related]
8. Androgens and estrogens: their interaction with stroma and epithelium of human benign prostatic hyperplasia and normal prostate.
Krieg M; Bartsch W; Thomsen M; Voigt KD
J Steroid Biochem; 1983 Jul; 19(1A):155-61. PubMed ID: 6193338
[TBL] [Abstract][Full Text] [Related]
9. Androgen metabolism in rat L6 myoblast cells; high formation of 5 alpha-androstane-3 alpha,17 beta-diol from testosterone.
Inoue S; Morimoto I; Yamashita S; Izumi M; Nagataki S
J Steroid Biochem; 1990 Jan; 35(1):77-81. PubMed ID: 2155350
[TBL] [Abstract][Full Text] [Related]
10. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
11. Three-month treatment with a long-acting gonadotropin-releasing hormone agonist of patients with benign prostatic hyperplasia: effects on tissue androgen concentration, 5 alpha-reductase activity and androgen receptor content.
Forti G; Salerno R; Moneti G; Zoppi S; Fiorelli G; Marinoni T; Natali A; Costantini A; Serio M; Martini L
J Clin Endocrinol Metab; 1989 Feb; 68(2):461-8. PubMed ID: 2465302
[TBL] [Abstract][Full Text] [Related]
12. Comparison of androgen metabolites in benign prostatic hypertrophy (BPH) and normal prostate.
Geller J; Albert J; Lopez D; Geller S; Niwayama G
J Clin Endocrinol Metab; 1976 Sep; 43(3):686-8. PubMed ID: 60347
[TBL] [Abstract][Full Text] [Related]
13. Dihydrotestosterone accumulation in genital skin fibroblasts derived from elderly men with prostatic hyperplasia.
Morimoto I; Eto S; Inoue S; Izumi M; Hara T; Saito Y; Nagataki S
J Clin Endocrinol Metab; 1992 Aug; 75(2):632-5. PubMed ID: 1379259
[TBL] [Abstract][Full Text] [Related]
14. Subnormal tissue 3 alpha-androstanediol and androsterone in prostatic hyperplasia.
Meikle AW; Stringham JD; Olsen DC
J Clin Endocrinol Metab; 1978 Oct; 47(4):909-13. PubMed ID: 95628
[TBL] [Abstract][Full Text] [Related]
15. In vitro studies on the effect of cofactors on the 5 alpha-reductase and 3 alpha- and 3 beta-hydroxysteroid reductase activities in the hyperplastic human prostate.
Lombardo ME; Hakky SI; Hall MK; Hudson PB
J Urol; 1992 Nov; 148(5):1605-10. PubMed ID: 1279222
[TBL] [Abstract][Full Text] [Related]
16. Androgen 5 alpha-reductase and 3 alpha-hydroxysteroid dehydrogenase activities in ventral prostate epithelial and stromal cells from immature and mature rats.
Orlowski J; Bird CE; Clark AF
J Endocrinol; 1983 Oct; 99(1):131-9. PubMed ID: 6579162
[TBL] [Abstract][Full Text] [Related]
17. Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.
Rizner TL; Lin HK; Peehl DM; Steckelbroeck S; Bauman DR; Penning TM
Endocrinology; 2003 Jul; 144(7):2922-32. PubMed ID: 12810547
[TBL] [Abstract][Full Text] [Related]
18. Androgen formation and metabolism in the pulmonary epithelial cell line A549: expression of 17beta-hydroxysteroid dehydrogenase type 5 and 3alpha-hydroxysteroid dehydrogenase type 3.
Provost PR; Blomquist CH; Godin C; Huang XF; Flamand N; Luu-The V; Nadeau D; Tremblay Y
Endocrinology; 2000 Aug; 141(8):2786-94. PubMed ID: 10919264
[TBL] [Abstract][Full Text] [Related]
19. Metabolism of dihydrotestosterone in human liver: importance of 3alpha- and 3beta-hydroxysteroid dehydrogenase.
Pirog EC; Collins DC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3217-21. PubMed ID: 10487690
[TBL] [Abstract][Full Text] [Related]
20. Changes in dihydrotestosterone metabolism associated with the development of canine benign prostatic hyperplasia.
Isaacs JT; Coffey DS
Endocrinology; 1981 Feb; 108(2):445-53. PubMed ID: 6161001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
